miR-217-5p NanomiRs Inhibit Glioblastoma Growth and Enhance Effects of Ionizing Radiation via EZH2 Inhibition and Epigenetic Reprogramming is a research paper published in Cancers (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →United States NIH
Grant: R01NS073611
United States NIH
Grant: R01NS096754
United States NIH
Grant: R01CA228133
United States NIH
Grant: P41EB028239
United States NIH
Grant: R37CA246699
United States NIH
Grant: R01NS120949
NICHD NIH HHS
Grant: P50 HD103538
NIH HHS
Grant: 1R01NS120949-04A1
NIBIB NIH HHS
Grant: R01 EB016721
NIH HHS
Grant: S10 OD016374
National Institutes of Health
Grant: 1S10OD016374-01
Zeiss LSM780 Confocal Microscope for a Core Facility
National Institutes of Health
Grant: 5R01NS120949-02
Molecular determinants of cellular heterogeneity and therapeutic resistance in GBM.
National Institutes of Health
Grant: 5R01CA228133-09
Gene Delivery Nanoparticles to Treat Glioblastoma
National Institutes of Health
Grant: 5R01NS073611-02
Brain Cancer Stem Cell Reprogramming by c-Met
National Institutes of Health
Grant: 5P41EB028239-02
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
National Institutes of Health
Grant: 4R37CA246699-06
A Platform Technology to Genetically Reprogram Cancer Cells for Enhanced Immunotherapy
National Institutes of Health
Grant: 5P50HD103538-02
Intellectual and Developmental Disabilities Research Centers 2020
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 5F99CA284254-02
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
National Institutes of Health
Grant: 5R01NS096754-03
Chromatin Modifications in GBM-Propagating Cells
FWCI
0.16
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals